Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function-Reference-Cited by-同舟云学术

Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function

Published:2004-03 Issue:2 Volume:36 Page:331-332
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Farmer D.G,McDiarmid S.V,Edelstein S,Renz J.F,Hisatake G,Cortina G,Fondevila C,Correa M,Rhodes S,Zafar A,Chavez Y,Yersiz H,Busuttil R.W

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference5 articles.

1. Clinical intestinal transplantation;Abu-Elmagd;Ann Surg,2001

2. Intestinal transplantation at the University of Nebraska Medical Center: 1990–2001;Langnas;Transplant Proc,2002

3. The efficacy of daclizumab for intestinal transplantation;Abu-Elmagd;Transplant Proc,2000

4. Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants;Carreno;Transplant Proc,2001

5. Basiliximab decreases the incidence of acute rejection after intestinal transplantation;Sudan;Transplant Proc,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-Cell Induction Therapies in Intestinal Transplantation;Gastroenterology Clinics of North America;2024-09

2. Updates in induction immunosuppression regimens for intestinal transplantation;Human Immunology;2024-05

3. Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival;Experimental and Clinical Transplantation;2022-12

4. Intestinal Transplantation;Organ Donation and Transplantation - Current Status and Future Challenges;2018-07-25

5. Intestinal transplantation;Current Opinion in Gastroenterology;2017-05